Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:monoclonal_antibody
|
| gptkbp:activities |
targets HE R2 protein
|
| gptkbp:approves |
gptkb:2013
gptkb:FDA |
| gptkbp:clinical_trial |
Phase III
|
| gptkbp:developed_by |
gptkb:Genentech
|
| https://www.w3.org/2000/01/rdf-schema#label |
Kadcyla
|
| gptkbp:ingredients |
trastuzumab emtansine
|
| gptkbp:is_used_for |
treatment of HE R2-positive breast cancer
|
| gptkbp:manager |
intravenous
|
| gptkbp:marketed_as |
gptkb:brand
|
| gptkbp:bfsParent |
gptkb:Trastuzumab_emtansine
|
| gptkbp:bfsLayer |
6
|